The Dow Jones Industrial Average initially surged over 500 points above Monday's close, reaching just above 52,300 before the opening bell, marking its highest level since September 22. This rally was driven by strong earnings reports from key components. Goldman Sachs (GS) reported third-quarter earnings of $17.01 per share, significantly surpassing forecasts of around $13.00. UnitedHealth (UNH) also beat forecasts and raised its outlook. Despite these positive results, both GS and UNH finished the session lower, with the reward for Goldman's 30% earnings beat being a smaller loss compared to JPMorgan Chase (JPM), which missed on profit and revenue but raised its 2026 net interest income forecast.
The Dow's gains were erased during the trading session, with the index falling through 52,000 to the 51,750 area within the first nine five-minute bars after the bell, making a low near 51,600 and closing just under 51,700. The declines were exacerbated by falls in Caterpillar (CAT) and Johnson & Johnson (JNJ), which together subtracted about 250 points from the Dow—more than the index's total loss. Citi reduced its share price target for Caterpillar by $150 to $950, expressing skepticism that data-centre spending for artificial intelligence justifies the current valuation. Johnson & Johnson, despite beating forecasts and raising its outlook, reported quarterly profit of only $0.09 per share due to a $5.5 billion charge to resolve talc lawsuits.
Technically, the Dow traded above its 50-day Exponential Moving Average (EMA) near 52,000 for the first time in over a month but finished back below it. The index has now given back more than a third of its climb from the October 1 low just above 50,500, which held just above the 200-day EMA. No forward-looking analyst opinions beyond Citi's downgrade of Caterpillar were provided in the article. [1]
CONCLUSION
Despite strong earnings beats from Goldman Sachs and UnitedHealth, the Dow Jones Industrial Average failed to hold its early gains, closing lower as declines in Caterpillar and Johnson & Johnson weighed on the index. The market reaction suggests that even robust earnings are not enough to sustain rallies amid broader concerns and negative analyst revisions. The session underscores ongoing volatility and the sensitivity of the Dow to both earnings surprises and negative outlooks.